Showing results (921-930 of 9,402) with videos related to

Sort By:
Pageof 941
Clinical Pharmacology and Therapeutics|May 17, 2012
Carboxylesterase 1 polymorphism impairs oseltamivir bioactivation in humansE K Tarkiainen, J T Backman, M Neuvonen, et al.
Clinical Pharmacology and Therapeutics|May 24, 2012
Impact of the β1-adrenoceptor Arg389Gly polymorphism on heart-rate responses to bisoprolol and carvedilol in heart-failure patientsT Rau, H-D Düngen, F Edelmann, et al.
Clinical Pharmacology and Therapeutics|May 24, 2012
Effects of CYP induction by rifampicin on tamoxifen exposureL Binkhorst, T van Gelder, W J Loos, et al.
Clinical Pharmacology and Therapeutics|June 28, 2017
A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin DosesRobin J Svensson, Rob E Aarnoutse, Andreas H Diacon, et al.
Clinical Pharmacology and Therapeutics|March 1, 1986
Quazepam and temazepam: effects of short- and intermediate-term use and withdrawalA Kales, E O Bixler, C R Soldatos, et al.
Clinical Pharmacology and Therapeutics|July 1, 1986
The role of cardiac beta-1 receptors in the hemodynamic response to a beta-2 agonistM H Strauss, R A Reeves, D L Smith, et al.
Clinical Pharmacology and Therapeutics|August 24, 2018
State-of-the-Art Review of HIV-TB Coinfection in Special PopulationsEthel D Weld, Kelly E Dooley
Clinical Pharmacology and Therapeutics|July 8, 2018
Molecular Modeling of Drug-Transporter Interactions-An International Transporter Consortium PerspectiveAvner Schlessinger, Matthew A Welch, Herman van Vlijmen, et al.
Clinical Pharmacology and Therapeutics|December 1, 1985
The effect of renal function on enalapril kineticsD T Lowenthal, J D Irvin, D Merrill, et al.
Clinical Pharmacology and Therapeutics|April 28, 2018
Forecasting Clinical Dose-Response From Preclinical Studies in Tuberculosis Research: Translational Predictions With RifampicinSebastian G Wicha, Oskar Clewe, Robin J Svensson, et al.
Pageof 941